Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1142.30 -0.30 (-0.03%)

51.11% Gain from 52W Low

85,408 NSE+BSE Volume

NSE 19 May, 2025 11:27 AM (IST)

14,007.9

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Alivus Life Sciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ALIVUS, BSE:543322 Alivus Life Sciences Ltd.

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

123 Votes:

Buy 75.61%

Sell 13.01%

Hold 11.38%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >